Users Discontinuing Anti-Obesity Injections Gain Back Pounds Far More Rapidly Than People Using Diet and Exercise

Fresh analysis reveals that individuals who discontinue new weight-loss injections like Wegovy and Mounjaro can put back on shed pounds far faster than those who stop conventional lifestyle plans.

Research printed in a prominent medical journal shows that while overweight individuals often shed substantial amounts of their total mass while on the medication, the mass is regained at an average rate of nearly a kilo each month once they quit.

"Users using these treatments need to be aware of the danger of fast rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb.

That rate of recovery implies a reversion to starting mass within about 18 months.

Analyzing Therapies

The research, which looked at 37 of studies involving thousands of participants, compared the effects of GLP-1 agonists with older methods.

The team emphasize that individuals who shed pounds through lifestyle changes alone typically have a more gradual weight regain—approximately 0.1 kg a month—once they finish.

The Reason for the Rapid Rebound

Experts suggest the mode of action of the jabs explains the amplified rebound.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which helps regulate appetite.

"Long-term administration of GLP-1 levels far above than the body's typical production might result in the body to produce less of its endogenous GLP-1, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this GLP-1 'fix' results in appetite is uncontrolled, making binge eating far more likely."

An Ongoing Issue?

The NHS suggest the injections for people with obesity-related health risks, alongside recommended diet and exercise modifications.

A number of clinicians argue that, given the high risk of weight regain, the therapy might need to be life-long.

This perspective is supported by drug manufacturers, who state that the findings "emphasize the chronic character of excess weight," comparing it to managing diseases like hypertension.

Patient Accounts

Users who have come off the jabs explain a intense return of hunger.

"It felt as if a switch activating and I was suddenly starving," described one woman.

The struggle is exacerbated if individuals have not developed sustainable lifestyle or habit changes during therapy.

Growing Adoption

Figures show that millions of adults in the UK have used these injections in the past year, with demand remaining high.

• Adoption is higher among women than males.
• The middle-aged demographic shows the greatest usage rates.
• Many access the drugs through private prescriptions rather than the NHS.

Ultimately, clinicians caution that while these medications are potent agents for weight loss, they are not a magic cure and long-term success likely depends on integrated behavioural support.